Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGON: Repeated GON Injections in Chronic Cluster Headache
NCT05324748Phase 3Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2022
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone in Cluster Headache (CH), sponsored by Leiden University Medical Center. Started Nov 2022; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT05324748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05324748.